TOP HEADLINES

Editor's Corner

French scientists roll out rapid diagnostic test for Ebola

As concern mounts over the deadly Ebola epidemic, French scientists are developing a diagnostic tool that works similar to a home pregnancy test and can quickly identify the virus through a tiny fluid sample.

InSilixa ropes in $13M from PointGuard Ventures and Morningside for molecular Dx tests

Silicon Valley startup InSilixa roped in $13M in financing to develop its innovative molecular diagnostic tests for drug-resistant bacteria and infections.

Cleveland Clinic crew identifies possible lung cancer biomarkers

Cleveland Clinic scientists believe they have identified possible blood biomarkers that could help detect lung cancer, based on the alteration of metabolic processes that happens to patients with the disease at various stages.

BioMérieux subsidiary nails Medicare coverage for breast cancer molecular test

A subsidiary of French in vitro diagnostics giant bioMérieux gained Medicare coverage for a new breast cancer test, a vital milestone necessary to compete in today's market.

Celgene takes equity stake in Sequenta and its precise Dx tech

Sequenta attracted new equity investment from Celgene and other unnamed parties that back the use of its technology in the drug development process and the creation of new ultraprecise diagnostic tests.

MORE NEWS

From Our Sister Sites

FierceBiotech

In this week's EuroBiotech Report, Google revealed further details of its $100 million (€79 million) European venture capital unit, which is hunting for biotechs and startups in other sectors from its digs in London. And more.

FierceMedicalDevices

Physical therapy to help stroke patients regain hand motor function after a stroke is so highly repetitive that patients often struggle through it. Irvine,CA-based startup Flint Rehabilitation Devices has launched a device that could make that process more effective and less excruciating.